# Effect of Renal Denervation on Stress, Hypertension and Anxiety Management

> **NCT05438446** · PHASE2 · UNKNOWN · sponsor: **Hippocration General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Hypertension Arterial
- Anxiety
- Stress

## Interventions

- **PROCEDURE:** Endovascular ultrasound renal denervation (Paradise renal denervation system, ReCor, CA, USA) (RDN)

## Key facts

- **NCT ID:** NCT05438446
- **Lead sponsor:** Hippocration General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-18
- **Primary completion:** 2023-10
- **Final completion:** 2023-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05438446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05438446, "Effect of Renal Denervation on Stress, Hypertension and Anxiety Management". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05438446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
